We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$1.03B
AUM Growth
+$329M
Cap. Flow
+$344M
Cap. Flow %
33.36%
Top 10 Hldgs %
75.89%
Holding
114
New
47
Increased
3
Reduced
20
Closed
22

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$110M
2
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$87.7M
3
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$53.3M
4
WORK
Slack Technologies, Inc.
WORK
+$49.5M
5
WTW icon
Willis Towers Watson
WTW
+$46.6M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$41.1M
2
DD icon
DuPont de Nemours
DD
+$29M
3
KBR icon
KBR
KBR
+$16.4M
4
CSTM icon
Constellium
CSTM
+$15.6M
5
CLGX
Corelogic, Inc.
CLGX
+$14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.72%
2 Financials 16.02%
3 Healthcare 12.41%
4 Technology 11.43%
5 Real Estate 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAACU
101
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
– –
-200,000
Closed -$2.27M
IPOD.WS
102
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$0 ﹤0.01%
50,000
– –
SOFIW
103
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
– –
-75,000
Closed -$244K
LCIDW
104
DELISTED
Lucid Group, Inc. Warrant
LCIDW
– –
-80,000
Closed -$126K
STPC.WS
105
DELISTED
Star Peak Corp II Warrants, each whole warrant exercisable for one share of Class A common stock at
STPC.WS
$0 ﹤0.01%
+20,000
New +$44.2K
CLOVW
106
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
– –
-216,666
Closed -$877K
RTPZ.U
107
DELISTED
Reinvent Technology Partners Z Units, each consisting of one Class A ordinary share and one-fifth o
RTPZ.U
– –
-40,000
Closed -$459K
FRX.U
108
DELISTED
Forest Road Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-th
FRX.U
– –
-250,000
Closed -$2.65M
THBR
109
DELISTED
Thunder Bridge Acquisition II, Ltd. Class A Ordinary Shares
THBR
– –
-200,000
Closed -$2.74M
BFT.WS
110
DELISTED
Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
BFT.WS
– –
-166,666
Closed -$818K
GHIVW
111
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
– –
-125,000
Closed -$551K
OAC.WS
112
DELISTED
Oaktree Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
OAC.WS
– –
-133,333
Closed -$547K
BMY.RT
113
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-492,449
Closed -$596K
CMAX
114
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-3,333
Closed -$1.5M
1 2 3 4
5

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return

Boussard & Gavaudan Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Boussard & Gavaudan Investment Management held 114 positions worth $1.03B, up 47% from $702M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Boussard & Gavaudan Investment Management deployed $344M of net new capital in Q1 2021, opening 47 new positions and adding to 3 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 708,375 shares worth $109M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 42% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alibaba, an estimated $41.1M trimmed.

  • Boussard & Gavaudan Investment Management's largest Q1 2021 buy was Alexion Pharmaceuticals: 708,375 shares worth $109M.
  • Boussard & Gavaudan Investment Management added most to Slack Technologies, Inc. in Q1 2021, an estimated $49.5M increase.
  • Boussard & Gavaudan Investment Management's biggest Q1 2021 reduction was Alibaba, cutting an estimated $41.1M.
  • Boussard & Gavaudan Investment Management fully exited DuPont de Nemours in Q1 2021, selling an estimated $29M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 76% of its $1.03B portfolio in Q1 2021.
  • Boussard & Gavaudan Investment Management opened 47 new positions and closed 22 in Q1 2021.
  • Boussard & Gavaudan Investment Management's portfolio value rose 47% quarter-over-quarter to $1.03B.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2021, filed 11 May 2021.